We are accepting Registration Requests for both Vaccine Summits.  Rooms are being filled on a first come, first served basis.  After your request form is submitted, you will receive an email to notify you whether or not a room is available for you.

The event will begin with dinner at 7:00 pm on Thursday, and will conclude on Saturday at 1:30 pm.  The educational portion of the program runs from the morning until lunch, with free time after lunch to relax and

enjoy yourself.

 Registration Fees include:

AGENDA OVERVIEW

• Update knowledge of current HPV vaccine recommendations including HPV vaccine efficacy and vaccine safety profile
•  Identify the major barriers that exist to HPV vaccination uptake and series completion
•  Review potential provider strategies to increase HPV vaccine uptake and series completion

Pertussis 2013: Epidemiology, Control, and Emerging Issues
Elizabeth Rausch-Phung, MD, MPH
Medical Director, Bureau of Immunization, NYSDOH

• Describe trends in pertussis disease in New York State (NYS) and the United States (US)
• Describe trends in DTaP and Tdap vaccination rates in NYS and the US
• Explain recent studies regarding the efficacy of DTaP and Tdap vaccination in the prevention of pertussis disease
• Explain and implement new Centers for Disease Control and Prevention (CDC) recommendations for pertussis post-exposure prophylaxis

The State of Preventable Diseases in New York, NYSIIS and VFC Update
Deborah Blog, MD
Director, Division of Epidemiology, NYSDOH

• Learn what preventable diseases are prevalent in New York State and what the NYSDOH is doing to address these issues
• Understand updates to the New York Immunization Information System (NYSIIS) and how to better use the data from NYSIIS
• Learn about changes in the Vaccines For Children (VFC) program as it relates to private Pediatric practices

Update on Influenza Vaccine 2013
David Pratt, MD
Former Commissioner of Public Health Services, Schenectady County, NY

• Explain the rationale for adding a second B strain to the seasonal influenza vaccine for 2013-14
• Describe the potential benefits of a cell culture derived vaccine for preventing influenza
• Explain the limitations of available flu vaccine in infants

Vaccines in the Pipeline
Joseph Domachowske, MD, FAAP
Professor of Pediatrics, Microbiology and Immunology
State University of New York Upstate Medical University, Syracuse, NY

• Describe the newest additions to our immunization armamentarium
• List vaccines that are likely to become available in the next several years
• Understand the basic process of vaccine discovery from identifying the concept through phase 1, 2 and 3 trials, and on to licensure

Update on the HIV Vaccine Advancement
Leonard Krilov, MD, FAAP
Chief, Pediatric Infectious Diseases
Vice Chair, Dept. of Pediatrics
Winthrop University Hospital, Mineola, NY

• Review the epidemiology and biology of HIV
• Discuss attempts to date for developing an HIV vaccine and difficulties encountered
• Address future directions for development of an HIV vaccine